Published in Eur Respir J on January 14, 2010
Clinical features, etiology, and outcomes of community-acquired pneumonia in patients with diabetes mellitus. Medicine (Baltimore) (2013) 0.90
Management of community-acquired pneumonia in older adults. Ther Adv Infect Dis (2014) 0.89
Pneumococcal vaccine and patients with pulmonary diseases. Am J Med (2014) 0.86
Influence of socioeconomic status on community-acquired pneumonia outcomes in elderly patients requiring hospitalization: a multicenter observational study. BMC Public Health (2010) 0.83
Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up. BMC Public Health (2012) 0.83
Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons. Hum Vaccin Immunother (2013) 0.80
Additive preventive effect of influenza and pneumococcal vaccines in the elderly: results of a large cohort study. Hum Vaccin Immunother (2013) 0.80
Pneumococcal Vaccination in High-Risk Individuals: Are We Doing It Right? Clin Vaccine Immunol (2016) 0.78
Cost-effectiveness analysis of pneumococcal polysaccharide vaccination from age 60 in São Paulo State, Brazil. Hum Vaccin (2011) 0.77
Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study. Hum Vaccin Immunother (2016) 0.76
Invasive pneumococcal disease rates linked to meteorological factors and respiratory virus circulation (Catalonia, 2006-2012). BMC Public Health (2016) 0.75
Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain. PLoS One (2017) 0.75
Factors associated with 30-day mortality in elderly inpatients with community acquired pneumonia during two influenza seasons. Hum Vaccin Immunother (2016) 0.75
[Pneumococcal vaccination for prevention of pneumonia]. Z Gerontol Geriatr (2015) 0.75
Pneumococcal and Influenza Vaccination Status of Hospitalized Adults with Community Acquired Pneumonia and the Effects of Vaccination on Clinical Presentation. Hum Vaccin Immunother (2017) 0.75
[Vaccination in the elderly]. Z Gerontol Geriatr (2013) 0.75
Cigarette smoking as a risk factor for tuberculosis in young adults: a case-control study. Tuber Lung Dis (1996) 2.62
Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet (2004) 2.33
Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538). AIDS (1996) 2.14
Incomplete overlapping of biological, clinical, and environmental information in molecular epidemiological studies: a variety of causes and a cascade of consequences. J Epidemiol Community Health (2002) 2.13
[Adolescents faced with addictive substances: tobacco, alcohol and noninstitutionalized drugs]. Med Clin (Barc) (1995) 2.05
[Evaluation of chromogenic medium CPS ID2 (bioMérieux) in urine cultures]. Enferm Infecc Microbiol Clin (1996) 2.02
[Efficiency of prevaccination screening of anti-HBc in the anti-hepatitis B vaccination programs]. Med Clin (Barc) (1992) 1.94
Heat requirement for the onset of the Olea europaea L. pollen season in several sites in Andalusia and the effect of the expected future climate change. Int J Biometeorol (2004) 1.54
Schistosomiasis and the Dogon country (Mali) Am J Trop Med Hyg (1992) 1.46
High-dose saquinavir plus ritonavir: long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic response. J Acquir Immune Defic Syndr (1999) 1.44
Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2000) 1.39
[Inflammatory pseudotumor of the liver presenting as fever of unknown origin]. Med Clin (Barc) (2001) 1.39
[Speed users (metamphetamines): a return journey between ecstasy (MDMA) and cocaine. Clinical, preventive and health-care questions]. Aten Primaria (2004) 1.39
[Retrospective evaluation of the effectiveness of the BCG vaccine campaign in newborns of Barcelona]. Med Clin (Barc) (1992) 1.39
[Prevalence of hepatitis C virus antibodies in homosexual men]. Med Clin (Barc) (1994) 1.39
[Susceptibility to measles, rubella and parotitis in young adults]. Med Clin (Barc) (1996) 1.38
[Excess length of stay attributable to nosocomial bacteremia: usefulness of the Hospitalization Appropriateness Protocol]. Med Clin (Barc) (1999) 1.38
[Screening for excessive alcohol consumption]. Med Clin (Barc) (1994) 1.38
Etiology of traveller's diarrhea in Spanish travellers to developing countries. Eur J Epidemiol (1993) 1.38
[Impact of smoking and alcohol consumption on mortality in the population of Barcelona [Spain]: 1983-1998]. Gac Sanit (2003) 1.38
Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother (2010) 1.38
[Preventive behaviors for the sexual transmission of AIDS, other infections, and pregnancy in high-school students]. Aten Primaria (1999) 1.37
Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients. AIDS (1999) 1.34
Passive smoking and risk of pulmonary tuberculosis in children immediately following infection. A case-control study. Tuber Lung Dis (1996) 1.32
Measurement of triceps skinfold thickness. An investigation of sources of variation. Br J Prev Soc Med (1971) 1.31
Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Clin Infect Dis (2001) 1.30
Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther (2004) 1.28
Social inequalities in health related behaviours in Barcelona. J Epidemiol Community Health (2000) 1.27
Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients. J Infect Dis (1998) 1.26
Changes in epidemiology, clinical features and severity of influenza A (H1N1) 2009 pneumonia in the first post-pandemic influenza season. Clin Microbiol Infect (2012) 1.24
Human immunodeficiency virus type 1 genetic evolution in patients with prolonged suppression of plasma viremia. Virology (1999) 1.23
Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study. Eur J Clin Microbiol Infect Dis (2006) 1.23
Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer. Clin Infect Dis (2000) 1.21
Altitude and hypertension. Mayo Clin Proc (1977) 1.19
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues. Antimicrob Agents Chemother (2000) 1.18
Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis (2000) 1.18
Prevalence of etravirine-associated mutations in clinical samples with resistance to nevirapine and efavirenz. J Antimicrob Chemother (2008) 1.17
Bradycardia, increased cardiac output, and reversal of pulmonary hypertension in altitude natives living at sea level. Br Heart J (1971) 1.17
Usefulness of PCR and antigen latex agglutination test with samples obtained by transthoracic needle aspiration for diagnosis of pneumococcal pneumonia. J Clin Microbiol (1999) 1.17
Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect (2012) 1.16
Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain. AIDS (1998) 1.14
Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries. AIDS (1998) 1.14
Smoking initiation and cessation by gender and educational level in Catalonia, Spain. Prev Med (2001) 1.12
Hepatitis A and B in children and adolescents--what can we learn from Puglia (Italy) and Catalonia (Spain)? Vaccine (2000) 1.12
Seroepidemiology of HIV-1 infection in a Catalonian penitentiary. AIDS (1990) 1.11
Serotype 3 is a common serotype causing invasive pneumococcal disease in children less than 5 years old, as identified by real-time PCR. Eur J Clin Microbiol Infect Dis (2011) 1.11
Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen. AIDS (2000) 1.10
Systemic blood pressure in white men born at sea level: changes after long residence at high altitudes. Am J Cardiol (1969) 1.09
A community outbreak of Legionnaires' disease: evidence of a cooling tower as the source. Clin Microbiol Infect (2006) 1.07
Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis (2006) 1.07
Early mortality in patients with community-acquired pneumonia: causes and risk factors. Eur Respir J (2008) 1.06
Aetiology of, and risk factors for, recurrent community-acquired pneumonia. Clin Microbiol Infect (2009) 1.05
Treatment of monocytes with interleukin (IL)-12 plus IL-18 stimulates survival, differentiation and the production of CXC chemokine ligands (CXCL)8, CXCL9 and CXCL10. Clin Exp Immunol (2006) 1.05
Occupation and bladder cancer in Spain: a multi-centre case-control study. Int J Epidemiol (1989) 1.05
Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clin Microbiol Infect (2010) 1.04
Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector. Blood (2000) 1.04
A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients. Kidney Int (2007) 1.03
Comparison of the LiPA HIV-1 RT test, selective PCR and direct solid phase sequencing for the detection of HIV-1 drug resistance mutations. J Virol Methods (1998) 1.03
Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. Clin Microbiol Infect (2011) 1.03
Exposure to environmental tobacco smoke at work and at home: a population based survey. Tob Control (2004) 1.02
Diet and bladder cancer in Spain: a multi-centre case-control study. Int J Cancer (1991) 1.02
Longitudinal study of heart disease in a Jamaican rural population. I. Prevalence, with special reference to ECG findings. Bull World Health Organ (1972) 1.01
Germination of Nosema algerae (Microspora) spores: conditional inhibition by D2O, ethanol and Hg2+ suggests dependence of water influxupon membrane hydration and specific transmembrane pathways. J Eukaryot Microbiol (1997) 1.01
Age at starting smoking and number of cigarettes smoked in Catalonia, Spain. Prev Med (1999) 1.00
Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes. Thorax (2009) 1.00
Vaccination coverage in indigenous and immigrant children under 3 years of age in Catalonia (Spain). Vaccine (2007) 0.99
Statins for community-acquired pneumonia: current state of the science. Eur J Clin Microbiol Infect Dis (2009) 0.99
Community-based seroepidemiological survey of HCV infection in Catalonia, Spain. J Med Virol (2001) 0.99
Mortality attributable to passive smoking in Spain, 2002. Tob Control (2007) 0.99
Italy and Austria before and after study: second-hand smoke exposure in hospitality premises before and after 2 years from the introduction of the Italian smoking ban. Indoor Air (2008) 0.98
[Epidemiology of traveler's diarrhea in Spanish tourists travelling in developing countries]. Med Clin (Barc) (1993) 0.98
Predictive factors, microbiology and outcome of patients with parapneumonic effusion. Eur Respir J (2011) 0.98
Discovery of ritonavir, a potent inhibitor of HIV protease with high oral bioavailability and clinical efficacy. J Med Chem (1998) 0.97
Coffee, pancreatic cancer, and K-ras mutations: updating the research agenda. J Epidemiol Community Health (2000) 0.96
Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone. Microb Drug Resist (2001) 0.96
In vitro activities of the new ketolide HMR 3647 (telithromycin) in comparison with those of eight other antibiotics against viridans group Streptococci isolated from blood of neutropenic patients with cancer. Antimicrob Agents Chemother (2001) 0.95
Urinary infection, renal lithiasis and bladder cancer in Spain. Eur J Cancer (1991) 0.94
Longitudinal study of heart disease in a Jamaican rural population. 3. Factors influencing changes in serial electrocardiograms. Bull World Health Organ (1972) 0.93
Prevalence of Neisseria meningitidis carriers in the school population of Catalonia, Spain. Epidemiol Infect (2001) 0.93
Predisposing factors and outcome of Staphylococcus aureus bacteremia in neutropenic patients with cancer. Eur J Clin Microbiol Infect Dis (2001) 0.93
Timing of antibiotic administration and outcomes of hospitalized patients with community-acquired and healthcare-associated pneumonia. Clin Microbiol Infect (2011) 0.92
Clinical features and outcomes of tuberculosis in solid organ transplant recipients. Transplant Proc (2012) 0.92
An in situ test to explore the responses of Scenedesmus acutus and Lepocinclis acus as indicators of the changes in water quality in lowland streams. Ecotoxicol Environ Saf (2011) 0.92
Timeliness of notification in infectious disease cases. Public Health Rep (1992) 0.92
Prevalence of Haemophilus influenzae pharyngeal carriers in the school population of Catalonia. Working Group on invasive disease caused by Haemophilus influenzae. Eur J Epidemiol (2000) 0.92
[Changes in seroepidemiology of hepatitis A virus infection in Catalonia in the period 1989-1996. Implications for new vaccination strategy]. Med Clin (Barc) (1999) 0.91
Prevalence of diabetes in Catalonia (Spain): an oral glucose tolerance test-based population study. Diabetes Res Clin Pract (1999) 0.91
[Self-care and health education in primary care]. Aten Primaria (1989) 0.91
Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain. The ERASE-2 Study Group. AIDS (2000) 0.91
The epidemiology of invasive Streptococcus pneumoniae disease in Catalonia (Spain). A hospital-based study. Vaccine (2002) 0.91
Evaluation of the smoke-free Olympics project. Promot Educ (1994) 0.91
US and color Doppler imaging of ocular and orbital disease in the pediatric age group. Radiographics (1996) 0.91
Longitudinal study of heart disease in a Jamaican rural population. 2. Factors influencing mortality. Bull World Health Organ (1972) 0.91
Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction. Vaccine (2008) 0.91
[Comparative study of human cutaneous sensitivity to 2 and 5 international units of the PPD RT 23 tuberculin with Tween 80]. Med Clin (Barc) (1992) 0.90
Nitrate dynamics in agricultural catchments deduced from groundwater dating and long-term nitrate monitoring in surface- and groundwaters. Sci Total Environ (2012) 0.90
Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies. Eur J Clin Microbiol Infect Dis (2010) 0.90